Prevalence and characteristics of pulmonary embolism in 1042 COVID-19 patients with respiratory symptoms: A nested case-control study. Issue 197 (January 2021)

• Record Type: Journal Article
• Authors: Planquette, Benjamin; Le Berre, Alice; Khider, Lina; Yannoutsos, Alexandra; Gendron, Nicolas; de Torcy, Marie; Mohamedi, Nassim; Jouveshomme, Stéphane; Smadja, David M.; Lazareth, Isabelle; Goudot, Guillaume; Fournier, Laure; Bruel, Cédric; Diehl, Jean Luc; Mourad, Jean-Jacques; Meyer, Guy; Priollet, Pascal; Messas, Emmanuel; Sanchez, Olivier; Beaussier, Hélène; Mirault, Tristan; Zins, Marc; Chatelier, Gilles; Emmerich, Joseph
• Is Part Of: Thrombosis research. Issue 197(2021)
• Page Start: 94
• Page End: 99
• Publication Date: 2021-01
• Subjects: Pulmonary embolism -- COVID-19 -- CTPA -- D-dimer; Thrombosis -- Periodicals; 616.135
• DOI: 10.1016/j.thromres.2020.11.001
• Languages: English
• ISSNs: 0049-3848

Abstract

Abstract: Introduction: Coronavirus disease 2019 (COVID-19) has been associated with cardiovascular complications and coagulation disorders. Previous studies reported pulmonary embolism (PE) in severe COVID-19 patients. Aim of the study was to estimate the prevalence of symptomatic PE in COVID-19 patients and to identify the clinical, radiological or biological characteristics associated with PE. Patients/methods: We conducted a retrospective nested case-control study in 2 French hospitals. Controls were matched in a 1:2 ratio on the basis of age, sex and center. PE patients with COVID-19 were compared to patients in whom PE was ruled out (CTPA controls) and in whom PE has not been investigated (CT controls). Results: PE was suspected in 269 patients among 1042 COVID-19 patients, and confirmed in 59 patients (5.6%). Half of PE was diagnosed at COVID-19 diagnosis. PE patients did not differ from CT and CTPA controls for thrombosis risk factors. PE patients more often required invasive ventilation compared to CTPA controls (odds ratio (OR) 2.79; 95% confidence interval (CI) 1.33–5.84) and to CT controls (OR 8.07; 95% CI 2.70–23.82). PE patients exhibited more extensive parenchymal lesions (>50%) than CT controls (OR 3.90; 95% CI 1.54–9.94). D-dimer levels were 5.1 (95% CI 1.90–13.76) times higher in PE patients than CTPA controls. Conclusions: Our results suggest a PE prevalence in COVID-19 patients close to 5% in the whole population and to 20% of the clinically suspected population. PE seems to be associated with more extensive lung damage and to require more frequently invasive ventilation. Highlights: Pulmonary embolism is highly prevalent in patients with COVID-19 pneumonia. In 1 out of 2 cases, pulmonary embolism was diagnosed on hospital admission. COVID-19 patients admitted to ICU were at high risk for pulmonary embolism. Pulmonary embolism was correlated with extension of COVID-19 lesions on CT scan.